92 related articles for article (PubMed ID: 21768724)
1. Intense FDG uptake in the spleen due to recent granulocyte-macrophage colony-stimulating factor administration: follow-up scan clarifying the situation.
Basu S; Baghel NS
J Cancer Res Ther; 2011; 7(2):228-9. PubMed ID: 21768724
[No Abstract] [Full Text] [Related]
2. [Transitory increase in splenic FDG uptake secondary to the administration of granulocyte colony stimulating factor (G-CSF)].
Ubieto MA; Banzo J
Rev Esp Med Nucl; 2009; 28(1):36. PubMed ID: 19232179
[No Abstract] [Full Text] [Related]
3. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M
Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162
[TBL] [Abstract][Full Text] [Related]
4. Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies.
Jacene HA; Ishimori T; Engles JM; Leboulleux S; Stearns V; Wahl RL
J Nucl Med; 2006 Jun; 47(6):950-6. PubMed ID: 16741304
[TBL] [Abstract][Full Text] [Related]
5. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.
Sugawara Y; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Nucl Med; 1999 Sep; 40(9):1456-62. PubMed ID: 10492365
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of diffusely increased splenic uptake on FDG-PET.
Liu Y
Nucl Med Commun; 2009 Oct; 30(10):763-9. PubMed ID: 19654562
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation.
Abdel-Dayem HM; Rosen G; El-Zeftawy H; Naddaf S; Kumar M; Atay S; Cacavio A
Clin Nucl Med; 1999 May; 24(5):319-22. PubMed ID: 10232468
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma.
Gundlapalli S; Ojha B; Mountz JM
Clin Nucl Med; 2002 Feb; 27(2):140-1. PubMed ID: 11786751
[No Abstract] [Full Text] [Related]
9. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.
Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K
Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448
[TBL] [Abstract][Full Text] [Related]
10. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen.
Stahl A; Weber WA; Avril N; Schwaiger M
Nuklearmedizin; 2000 Dec; 39(8):241-5. PubMed ID: 11189901
[TBL] [Abstract][Full Text] [Related]
11. Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration.
Chiang SB; Rebenstock A; Guan L; Burns J; Alavi A; Zhuang H
Clin Nucl Med; 2003 Sep; 28(9):786-8. PubMed ID: 12973012
[TBL] [Abstract][Full Text] [Related]
12. Changing biodistribution of gallium during G-CSF treatment in non- Hodgkin's disease.
Maffioli LS; Castellani MR; Bombardieri E; Devizzi L; Draisma A; Pauwels E
Eur J Nucl Med; 1999 Jan; 26(1):68-9. PubMed ID: 10048953
[No Abstract] [Full Text] [Related]
13. [Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy].
Lorenzen J; de Wit M; Buchert R; Igel B; Bohuslavizki KH
Nuklearmedizin; 1999; 38(8):333-6. PubMed ID: 10615668
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle uptake detected on FDG PET 48 hours after exertion.
Gradinscak DJ; Fulham MJ; Mohamed A; Constable CJ
Clin Nucl Med; 2003 Oct; 28(10):840-1. PubMed ID: 14508278
[No Abstract] [Full Text] [Related]
15. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
16. Ovarian F-18 FDG uptake in a premenopausal woman.
Choi SJ; Hyun IY
Clin Nucl Med; 2006 Mar; 31(3):161-3. PubMed ID: 16495739
[No Abstract] [Full Text] [Related]
17. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
18. Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.
Yamane T; Daimaru O; Ito S; Yoshiya K; Nagata T; Ito S; Uchida H
J Nucl Med; 2004 Nov; 45(11):1838-42. PubMed ID: 15534052
[TBL] [Abstract][Full Text] [Related]
19. Pain-related F-18 FDG uptake of the corrugator supercilii muscles in PET/CT.
Burger IA; Schmid DT; Hany TF
Clin Nucl Med; 2012 Jan; 37(1):e11-2. PubMed ID: 22157050
[No Abstract] [Full Text] [Related]
20. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
